S, K., E, L., B, L., K, R., A, H., & AR, M. (2026). Integrating In-vitro Permeability Assays within PBPK Modeling to Predict CNS Distribution of Standard and Engineered Antibodies. The AAPS journal, 28(3), . https://doi.org/10.1208/s12248-026-01233-y
Chicago Style (17th ed.) CitationS, Kim, Lessard E, Ling B, Rennie K, Haqqani A, and Maharaj AR. "Integrating In-vitro Permeability Assays Within PBPK Modeling to Predict CNS Distribution of Standard and Engineered Antibodies." The AAPS Journal 28, no. 3 (2026). https://doi.org/10.1208/s12248-026-01233-y.
MLA (9th ed.) CitationS, Kim, et al. "Integrating In-vitro Permeability Assays Within PBPK Modeling to Predict CNS Distribution of Standard and Engineered Antibodies." The AAPS Journal, vol. 28, no. 3, 2026, https://doi.org/10.1208/s12248-026-01233-y.